In cancers like pancreatic ductal adenocarcinoma, CXCL10-CXCR3 signaling maintains an inflammatory, anti-tumor M1 macrophage phenotype, and blockade of this axis promotes a shift to a tumor-supportive M2 phenotype [25]. Here, CXCL10 is linked to cancer.